Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin versus botulinum toxin + Profhilo for neck rejuvenation
IRCT20201204049589N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-blind trial of botulinum toxin type A and hyaluronic acid (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Wrinkle Severity Rating Scale. Started Aug 2019; status: completed.
02
Drugs
botulinum toxin type Ahyaluronic acid
Beyond the preview
Go deeper on IRCT20201204049589N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201204049589N1.